Morgan Stanley’s Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock VHAQ.U Stock Holding History

Morgan Stanley’s Portfolio VHAQ.U Stock Details VHAQ.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-250	Closed	-$3K	–	7998
2022 Q3	$3K	Buy	250 +229	+1,090%	+$2.37K	﹤0.01%	7416
2022 Q2	$0	Sell	21 -1,343	-98%	-$13.8K	﹤0.01%	8081
2022 Q1	$13K	Hold	1,364	–	–	﹤0.01%	7324
2021 Q4	$14K	Hold	1,364	–	–	﹤0.01%	7355
2021 Q3	$14K	Hold	1,364	–	–	﹤0.01%	7229
2021 Q2	$14K	Hold	1,364	–	–	﹤0.01%	7141
2021 Q1	$14K	Buy	+1,364	New	+$14.4K	﹤0.01%	6849

Other funds holding VHAQ.U

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Morgan Stanley's VHAQ.U Position: Q4 2022 in Review

Morgan Stanley sold out of Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock (VHAQ.U) in Q4 2022, closing a stake of 250 shares — an estimated $3K sold.

Morgan Stanley first reported a position in VHAQ.U in Q1 2021 and held it in 7 quarters. The position peaked at $14K in Q4 2021. 1 fund tracked by Wall St. Rank holds VHAQ.U as of Q4 2022.

Morgan Stanley reported no remaining Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock position as of Q4 2022 after selling out during the quarter.
Morgan Stanley sold 250 Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock shares in Q4 2022, an estimated $3K.
Morgan Stanley first reported a position in Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock in Q1 2021 and held it in 7 quarters.
Morgan Stanley's Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock position peaked at $14K in Q4 2021.
1 fund tracked by Wall St. Rank held Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.